In a post to its corporate LinkedIn page, Veeva (VEEV) offered congratulations to GSK‘s (GSK) SVP of global medical affairs and technology, Kieron Scrutton, on the successful Vault CRM go-live across Europe.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VEEV:
- Options Volatility and Implied Earnings Moves This Week, August 25 – August 29, 2025
- VEEV Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Cautious Outlook on Veeva Systems Amid Growth Sustainability Concerns and Sector Risks
- Veeva Systems: Hold Rating Amid High Expectations and Macroeconomic Concerns
- Veeva price target raised to $268 from $230 at Truist